Mexico in talks to receive Indian vaccine and cancer drug technology

Mexico's Foreign Minister Marcelo Ebrard gestures during a meeting with Spain's Foreign Minister Jose Manuel Albares as part of an official visit at the Foreign Ministry Building (SRE), in Mexico City, Mexico, March 9, 2022. REUTERS/Edgard Garrido
MEXICO CITY, March 30 (Reuters) – Mexican Foreign Minister Marcelo Ebrard has begun talks to receive medical technology from Indian companies to produce vaccines and cancer drugs in Mexico on Wednesday, the ministry said.
The minister and Mexican delegates held meetings in India with the country's health, science and traditional medicine ministry ministries, along with representatives from two Indian laboratories.
Talks continue on Thursday with Biological E. Limited, another pharmaceutical, to "reach a transfer agreement of Indian technology that would allow basic vaccines to be developed in Mexico," Mexico's foreign ministry said in a press release.
The two countries also agreed on Wednesday to create a joint accelerator fund for biotech and aerospace projects, as well as to work on projects to digitize health information.
Thursday is Ebrard's last day on a tour through the Middle East and India, his longest trip as foreign minister. read more
Our Standards: The Thomson Reuters Trust Principles.
Sign up to our health newsletter to keep up with the latest healthcare trends and pharmaceutical news.
Subscribe to our newsletter to get all the news you need to start your day.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved